Document:

Form of Indemnification Agreement

 Exhibit 10.2 
  
 INDEMNIFICATION AGREEMENT 
  
 INDEMNIFICATION AGREEMENT, dated as of
                     by and between ViroPharma Incorporated, a Delaware corporation (“Company”), and the officer or director of the
Company whose name appears on the signature page of this Agreement (such officer or director, together with any corporation, partnership, trust, association or other entity on whose behalf the director is or was serving or with whom such director is
or was otherwise employed, affiliated or associated in connection with his service as a director of the Company, being hereinafter referred to as the “Indemnitee”). 
  
 WHEREAS, highly competent persons are becoming more reluctant to serve as officers or directors of corporations unless they
are provided with reasonable protection through insurance or indemnification against risks of claims and actions against them arising out of their service to, and activities on behalf of corporations; and 
  
 WHEREAS, the Board of Directors of the Company (the “Board”) has
determined that the Company should act to assure such persons that there will be increased certainty of such protection in the future; and 
  
 WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify such persons to the fullest extent
permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified. 
  
 NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee, intending to be legally bound, do hereby
covenant and agree as follows: 
  
 Section 1. Services by
Indemnitee. Indemnitee agrees to serve as an officer or director of the Company or other corporation, partnership, joint venture or other enterprise affiliated with the Company (all of which are collectively referred to as an
“Affiliate”) as an officer or director. Notwithstanding anything contained herein, this Agreement shall not create a contract of employment between the Company or an Affiliate and the Indemnitee and the termination of the Indemnitee’s
relationship with the Company or an Affiliate by either party hereto shall not be restricted by this Agreement. 
  
 Section 2. Indemnification. Subject to Section 13 below, the Company shall indemnify Indemnitee for, and hold Indemnitee harmless from and
against, any losses, liabilities, claims; judgments, fines or Expenses (as defined below) at any time incurred by, or assessed against Indemnitee arising out of or in connection with the service of Indemnitee as an officer, director, advisory
director, Board Committee member or officer of the Company or of an Affiliate (collectively referred to as a “Officer or Director of the Company”) to the fullest extent permitted by the laws of the State of Delaware in effect on the date
hereof or as such laws may from time to time hereafter be 

  

 
amended to increase the scope of such permitted indemnification, provided, however, the Company shall indemnify an Indemnitee in connection with a
proceeding instituted by an Indemnitee on behalf of the Company, and in Indemnitee’s capacity as an Officer or Director of the Company (other than an action to enforce indemnification rights under this Agreement), only if such Proceeding (as
defined below) is authorized by the Board of Directors in the manner set forth herein. Without diminishing the scope of the indemnification provided by this Section 2, the rights of indemnification of Indemnitee provided hereunder shall include but
shall not be limited to those rights set forth hereinafter. 
  
 Section 3. Action or Proceeding Other Than an Action by or in the Right of the Company. Subject to Section 13 below, the Indemnitee shall be entitled to the indemnification rights provided herein if Indemnitee is a person who
was or is made a party or is threatened to be made a party to any pending, completed or threatened Proceeding other than an action by or in the right of the Company, by reason of (a) the fact that Indemnitee is or was an Officer or Director of the
Company, an Affiliate or any other entity which Indemnitee is or was serving at the request of the Company, or (b) anything done or not done by Indemnitee in any such capacity. Pursuant to this Section, Indemnitee shall be indemnified against
Expenses, losses, claims, liabilities, judgments, fines and amounts paid in settlement (subject to Section 7 below) incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding, if Indemnitee acted in good faith and in a
manner Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company, and, with respect to any criminal Proceeding, had no reasonable cause to believe his conduct was unlawful. 
  
 Section 4. Actions by or in the Right of the Company. Subject
to Section 13 below, Indemnitee shall be entitled to the indemnification rights provided herein if Indemnitee is a person who was or is made a party or is threatened to be made a party to any pending, completed or threatened Proceeding brought by or
in the right of the Company to procure a judgment in its favor by reason of (a) the fact that Indemnitee is or was an Officer or Director of the Company, an Affiliate or any other entity which Indemnitee is or was serving at the request of the
Company, or (b) anything done or not done by Indemnitee in any such capacity. Pursuant to this Section 4, Indemnitee shall be indemnified against Expenses, losses, claims, liabilities, judgments, fines and amounts paid in settlement (subject to
Section 7 below) incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company.
Notwithstanding the foregoing provisions of this Section 4, no such indemnification shall be made in respect of any claim, issue or matter as to which Delaware law expressly prohibits such indemnification by reason of an adjudication of liability of
Indemnitee to the Company (or otherwise); provided, however, that in such event such indemnification shall nevertheless be made by the Company to the extent that the Court of Chancery of the State of Delaware or the court in which such action
or suit was brought shall determine equitable under the circumstances. 
  

 2 

 Section 5. Indemnification for Costs, Charges and Expenses of Party Who is Wholly or Partly
Successful. Subject to Sections 7 and 13 below, notwithstanding any provision of this Agreement to the contrary, to the extent that Indemnitee has been wholly successful on the merits or otherwise involved in any Proceeding on any claim, issue
or matter, Indemnitee shall be indemnified against all Expenses incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise,
as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee to the maximum extent permitted by law, against all Expenses, judgments, penalties, fines and amounts paid in settlement,
incurred by Indemnitee. For purposes of this Section and without limitation, the termination of any such claim, issue or matter by dismissal with or without prejudice shall be deemed to be wholly successful result as to such claim, issue or matter.

  
 Section 6. Indemnification for Expenses of a Witness.
Notwithstanding any other provision of this Agreement, to the extent that the Indemnitee is, by reason of the fact that he or she is or was a Director of the Company, an Affiliate or any other entity which Indemnitee is or was serving at the request
of the Company, a witness in any Proceeding, Indemnitee shall be indemnified by the Company against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. 
  
 Section 7. Notification and Defense of Claim. Not later than
thirty (30) days after receipt by Indemnitee of notice of the commencement of any Proceeding, Indemnitee will, if a claim in respect thereof is made against the Company under this Agreement, notify the Company of the commencement thereof; but the
omission so to notify the Company will not relieve it from any liability which it may have to Indemnitee otherwise than under this Agreement. With respect to any such Proceeding as to which Indemnitee notifies the Company of the commencement
thereof: 
  
 (a) the Company (subject to this Section 7) will be
entitled to participate therein at its own expense; 
  
 (b) except
as otherwise provided below, the Company may, assume the defense thereof, with counsel reasonably satisfactory to Indemnitee. After notice from the Company to Indemnitee of its election to assume the defense thereof, the Company will not be liable
to Indemnitee under this Agreement for any legal or other expenses subsequently incurred by Indemnitee in connection with the defense thereof except for reasonable costs of investigation or otherwise as provided below. Indemnitee shall have the
right to employ separate counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee unless (i) the employment of counsel
by Indemnitee has been authorized by the Company, (ii) Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of the defense of such Proceeding, or (iii) the Company
shall not in fact have employed counsel to assume the defense of such Proceeding, in each of which cases the fees and expenses of Indemnitee’s separate counsel shall be at the expense of the 

  

 3 

 
Company. The Company shall not be entitled to assume the defense of any Proceeding brought by or on behalf of the Company or as to which Indemnitee shall
have made the conclusion provided for in (ii) above; and 
  
 (c)
notwithstanding anything to the contrary set forth in this Agreement, the Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any action or claim effected without its written consent, which
shall not be unreasonably withheld; provided however that if the Company shall not respond to Indemnitee’s request for written consent within seven (7) days from and after Indemnitee’s request therefor, Indemnitee shall be permitted
to settle any Proceeding and the Company shall be liable to indemnify Indemnitee hereunder. The Company shall not be permitted to settle any Proceeding which shall adversely affect Indemnitee without his or her prior written consent. 
  
 Section 8. Advancement of Expenses and Costs. All Expenses
incurred by or on behalf of Indemnitee or reasonably expected by the Indemnitee in good faith to be incurred by the Indemnitee within any three month period shall be paid by the Company from time to time in advance of the final disposition of such
Proceeding within thirty days after the receipt by the Company of a statement or statements from Indemnitee requesting from time to time such advance or advances. Indemnitee’s entitlement to such advancement of Expenses shall include those
incurred in connection with any proceeding by Indemnitee seeking an adjudication or award in arbitration pursuant to this Agreement. Such statement or statements shall reasonably evidence such expenses incurred or reasonably expected to be incurred
by Indemnitee in connection therewith and shall include or be accompanied by a written undertaking by or on behalf of Indemnitee to repay such amount if it shall ultimately be determined that Indemnitee is not entitled to be indemnified therefor
pursuant to the terms of this Agreement. 
  
 Section 9.
Procedure for Determination of Entitlement to Indemnification. 
  
 (a) When seeking indemnification under this Agreement, Indemnitee shall submit a written request for indemnification to the Company in the manner contemplated by Section 7 hereof; which request shall include documentation or information
which is reasonably necessary for the Company to make a good faith determination of Indemnitee’s entitlement to indemnification hereunder and which is reasonably available to Indemnitee. Such determination of Indemnitee’s entitlement to
indemnification shall be made not later than 30 days after receipt by the Company of the Indemnitee’s written request for indemnification. The Secretary of the Company shall, promptly upon receipt of Indemnitee’s request for
indemnification advise the Board that Indemnitee has made such request for indemnification. 
  
 (b) The entitlement of the Indemnitee to indemnification under this Agreement shall be determined in the specific case by a majority vote of a quorum of the Board consisting of Disinterested Directors (as hereinafter
defined). If such a quorum is not obtainable or if such majority vote of Disinterested Directors so directs, the determination shall be made by Independent Counsel (as defined below). All fees and 

  

 4 

 
expenses of the Independent Counsel incurred in connection with acting pursuant to this Agreement shall be borne by the Company. 
  
 (c) In the event the determination of entitlement is to be made by
Independent Counsel, such Independent Counsel shall be selected by the Board and approved by Indemnitee. Upon failure of the Board to so select such Independent Counsel or upon failure of Indemnitee to so approve, such Independent Counsel shall be
selected by the Chancellor of the State of Delaware or such other person as the Chancellor shall designate to make such selection. 
  
 (d) If such majority of Disinterested Directors or Independent Counsel shall have determined that Indemnitee is not entitled to indemnification to the
full extent of Indemnitee’s request, Indemnitee shall have the right to seek a determination as to his or her entitlement to indemnification in accordance with the procedures set forth in Section 9 hereof. 
  
 Section 10. Presumptions and Effect of Certain Proceedings.

  
 (a) Upon making such request for indemnification, Indemnitee
shall be presumed to be entitled to indemnification hereunder and the Company shall have the burden of proof in determining that Indemnitee is not so entitled. If a determination of whether Indemnitee is entitled to indemnification hereunder is not
made in accordance with Section 9 hereof within 30 days after receipt by the Company of such request, the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be absolutely entitled to such
indemnification, absent (i) misrepresentation by Indemnitee of a material fact in the request for indemnification or (ii) a final judicial determination that all or any part of such indemnification is expressly prohibited by Delaware law; provided,
however, that at the initiation of an action for a determination as to the Indemnitee’s right to indemnification under Delaware law, the Indemnitee shall at the outset of such judicial determination, undertake to reimburse the Company upon such
final determination. The termination of any Proceeding by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, adversely affect the rights of Indemnitee to indemnification
hereunder except as may be specifically provided herein, or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or create a
presumption that with respect to any criminal action or proceeding that Indemnitee had reasonable cause to believe the Indemnitee’s conduct was unlawful. 
  

(b) For purposes of any determination of good faith hereunder, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is
based on the records or books of account of the Company, an Affiliate or any other entity Indemnitee is or was serving at the request of the Company, including financial statements, or on information supplied to Indemnitee by the officers of the
Company or an Affiliate in the course of their duties, or on the advice of legal counsel for the Company or an Affiliate or on information or records given or reports made to the Company or an Affiliate by an 

  

 5 

 
independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or an Affiliate. The provisions of
this Section 10(b) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement. 
  
 (c) The knowledge and/or action, or failure to act, of any director, officer,
agent or employee of the Company, an Affiliate or any other entity Indemnitee is or was serving at the request of the Company shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

  
 Section 11. Remedies in Cases of Determination not to
Indemnify or to Advance Expenses. 
  
 (a) In the event
that (i) a determination is made that Indemnitee is not entitled to indemnification hereunder, (ii) advances are not made pursuant to Section 8 or (iii) payment has not been timely made following a determination of entitlement to indemnification
pursuant to Sections 9 and 10, Indemnitee shall be entitled to seek a final adjudication in an appropriate court of the State of Delaware or any other court of competent jurisdiction of Indemnitee’s entitlement to such indemnification in
advance. Alternatively, Indemnitee at Indemnitee’s option may seek an award in arbitration to be conducted by a panel of three arbitrators in Delaware or in Philadelphia, Pennsylvania, pursuant to the rules of the American Arbitration
Association then prevailing, such award to be made within 60 days following the filing of the demand for arbitration. The Company shall not oppose Indemnitee’s right to seek arbitration of any such claim. 
  
 (b) In the event a determination has been made, in whole or in part, that
Indemnitee is not entitled to indemnification, any such judicial proceeding or arbitration shall be made de novo and Indemnitee shall not be prejudiced by reason of any prior determination that Indemnitee is not entitled to indemnification.

  
 (c) If a determination is made or deemed to have been made
pursuant to the terms of Section 9 or Section 10 hereof that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration in the absence of (i) a misrepresentation of a
material fact by Indemnitee or (ii) a final judicial determination that all or any part of such indemnification is expressly prohibited by law. 
  
 (d) Subject to Section 13 below, the Company agrees that it shall be precluded from asserting that the procedures and presumptions of this Agreement are
not valid, binding and enforceable, and further agrees to stipulate in any such court or before any such arbitrators that the Company is bound by all the provisions of this Agreement and is precluded from making any assertion to the contrary.

  
 (e) If, after the Company has previously determined that
Indemnitee is not entitled to indemnification, a court or arbitration panel determines that Indemnitee is so 

  

 6 

 
entitled hereunder, to the extent deemed appropriate by the arbitrators or the court, interest shall be paid by the Company to the Indemnitee at a reasonable
interest rate from and after the date on which the Company had denied Indemnitee’s entitlement to indemnification hereunder, for amounts which the Company indemnifies the Indemnitee. 
  
 Section 12. Expenses Incurred by Indemnitee to Enforce this Agreement. Reasonable expenses incurred by
Indemnitee in connection with the preparation and submission of Indemnitee’s request for indemnification hereunder shall be borne by the Company. In the event that Indemnitee is a party to or intervenes in any proceeding in which the validity
or enforceability of this Agreement is at issue or seeks an adjudication or award in arbitration to enforce Indemnitee’s rights under, or to recover damages for breach of, this Agreement, Indemnitee, if Indemnitee prevails in whole in such
action, shall be entitled to recover from the Company and shall be indemnified by the Company against, any Expenses incurred by Indemnitee. If it is determined that the Indemnitee is entitled to indemnification of part (but not all) of the
indemnification so requested, Expenses incurred in seeking enforcement of such partial indemnification shall be reasonably prorated among such claims, issues or matters. 
  
 Section 13. Limitations on Indemnification. Notwithstanding anything to the contrary set forth in this
Agreement, and not in limitation of the restrictions of the Company’s liability under applicable law, no indemnity pursuant to this Agreement shall be paid by the Company: (a) on account of any claim against Indemnitee for an accounting of
profits made from the purchase or sale by Indemnitee of securities of the Company pursuant to the provisions of Section 16(b) of the Securities Exchange Act of 1934 and amendments thereto or similar provisions of any federal, state or local
statutory law; (b) on account of Indemnitee’s conduct that was knowingly fraudulent or deliberately dishonest, or that constituted willful misconduct; (c) on account of Indemnitee’s conduct that constituted a breach of Indemnitee’s
duty of loyalty to the Company or resulted in any personal profit or advantage to which Indemnitee was not legally entitled; (d) for which payment has actually been made to Indemnitee under a valid and collectable insurance policy or under a valid
and enforceable indemnity clause, bylaw or agreement, except in respect of any excess beyond payment under such insurance, clause, by-law or agreement; (e) if indemnification is not lawful (and, in this respect, both the Company and Indemnitee have
been advised that the Securities and Exchange Commission believes that indemnification for liabilities arising under the federal securities laws is against public policy and is, therefore, unenforceable and that claims for indemnification should be
submitted to appropriate courts for adjudication); or (f) in connection with any Proceeding by Indemnitee against the Company or its directors, officers, employees or other agents other than as set forth in Section 12 above, unless (i) such
indemnification is expressly required to be made by law, (ii) the Proceeding was authorized by the Board of Directors of the Company, or (iii) such indemnification is provided by the Company, in its sole discretion, pursuant to the powers vested in
the Company under the Delaware General Corporation Law; provided, however, that until the final and non-appealable determination by a court of competent jurisdiction as to any of the foregoing, the Indemnitee shall be entitled to indemnification
hereunder (including Expenses) so long as the Indemnitee executes an undertaking to reimburse the Company promptly upon any such determination. 
  

 7 

 Section 14. Non-Exclusivity. The rights of indemnification and to receive advances as
provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Company’s, any Affiliate’s or other entity’s certificate of incorporation or other
organizational document, the By-Laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration, rescission or replacement of this Agreement or any provision hereof shall be effective as to Indemnitee
with respect to any action taken or omitted by such Indemnitee in Indemnitee’s position with the Company or an Affiliate or any other entity which Indemnitee is or was serving at the request of the Company prior to such amendment, alteration,
rescission or replacement. 
  
 Section 15. Duration of
Agreement. This Agreement shall apply to any claim asserted and any Expenses incurred in connection with any claim asserted on or after the effective date of this Agreement and shall continue until and terminate upon the later of: (a) 10
years after Indemnitee has ceased to occupy any of the positions or have any of the relationships described in Sections 2, 3 or 4 of this Agreement; or (b) the final non-appealable termination of all pending or threatened Proceedings of the kind
described herein with respect to Indemnitee. This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisee, executors,
administrators or other legal representatives. 
  
 Section 16.
Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement
(including without limitation, all portions of any Sections of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or
impaired thereby; and (b) to the fullest extent possible, the provisions of this Agreement (including, without limitation, all portions of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that
are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable. 
  
 Section 17. Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the
existence of this Agreement. 
  
 Section 18. Headings.
The headings of the Sections of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. 
  

 8 

 Section 19. Definitions. For purposes of this Agreement: 
  
 (a) “Disinterested Director” shall mean a director
of the Company who is not or was not a party to the Proceeding in respect of which indemnification is being sought by Indemnitee. 
  
 (b) “Expenses” shall include all reasonable attorneys’ fees and costs, retainers, court costs, transcripts, fees of
experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses reasonably incurred in connection with asserting or defending claims.

  
 (c) “Independent Counsel” shall
mean a law firm or lawyer that neither is presently nor in the past five (5) years has been retained to represent: (i) the Company or Indemnitee in any matter material to either such party, or (ii) any other party to the Proceeding giving rise to a
claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any firm or person who, under the applicable standards of professional conduct then prevailing, would have a conflict of
interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s right to indemnification under this Agreement. 
  
 (d) “Proceeding” includes any action, suit, arbitration, alternate dispute resolution mechanism, investigation, administrative
hearing or any other proceeding whether civil, criminal, administrative or investigative, provided, however, that the term “Proceeding” shall include any action instituted by an Indemnitee (other than an action to enforce indemnification
rights under this Agreement) only if such action is authorized in the manner set forth in Section 8 hereof. 
  
 Section 20. Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing
by both of the parties hereto, provided, however, that any such mutually agreed upon supplement, amendment or modification shall not require stockholder approval if such modification, amendment or supplement is made to conform to any
amendment or revision of Delaware General Corporation Law which expands the Indemnitee’s right to indemnification thereunder or is otherwise beneficial to Indemnitee or in the sole judgment of the Board of Directors of the Company, does not
materially and adversely affect the rights and protection of the Company. 
  
 Section 21. No Duplicative Payment. The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that Indemnitee has
otherwise actually received such payment under any insurance policy, contract, agreement or otherwise. 
  

 9 

 Section 22. Notices. All notices, requests, demands and other communications hereunder
shall be in writing and shall be deemed to have been duly given if (i) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, or (ii) mailed by certified or registered mail with postage
prepaid, on the third business day after the date on which it is so mailed: 
  
 (a) If to Indemnitee, to the address appearing on the signature page hereof. 
  
 (b) If to the Company to: 
  
       ViroPharma Incorporated 
       397 Eagleview Boulevard 
       Exton, PA 19341 
       Attention: General Counsel 
  
 or such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case
may be. 
  
 Section 23. Governing Law. This
Agreement shall be governed by, and construed and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the conflict of laws doctrines of Pennsylvania or any other jurisdiction. 
  

 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

  

			
	 VIROPHARMA INCORPORATED

		
	 By:
	 	 
	 	 	 Michel de Rosen

	 	 	 CEO and President

			
	
	 INDEMNITEE

	
	 
	 [NAME]
	 	 
	 [TITLE]
	 	 
		
	 Address:
	 	 
		
	 	 	 
		
	 	 	 

  

 11ViroPharma Severance Plan

 EXHIBIT 10.37 
  
 VIROPHARMA INCORPORATED 
 SEVERANCE
PAY PLAN 
  
 I. PURPOSE 
  
 1.1. General Purpose. The Plan is intended to provide separation
benefits to certain employees of ViroPharma Incorporated and its affiliates and subsidiaries who are separated from service involuntarily. The Plan supersedes all prior plans or programs providing severance or separation benefits, whether written or
unwritten. 
  
 1.2. Coverage Under ERISA. It is the
intention of the Company that the Plan be a welfare benefit plan, as defined in the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). 
  
 II. DEFINITIONS 
  
 2.1. Defined Terms. Whenever used in the Plan, unless the context clearly indicates otherwise, the following words shall have the following
meanings: 
  
 (a) “Administrator” means
the person or persons designated by the Board of Directors of the Company to administer the Plan. 
  
 (b) “Company” means ViroPharma Incorporated, or any successor thereto. 
  
 (c) “Employee” means any person who is regularly
employed by a Participating Company for 30 or more hours per week, who is paid from a Participating Company payroll and who is not covered by a collectively bargained agreement to which any Participating Company is a party. 
  
 (d) “ERISA” means the Employee Retirement Income
Security Act of 1974, as amended, and regulations issued thereunder. 
  
 (e) “Month of Salary” means an amount equal to the Participant’s annualized base salary divided by twelve. 
  
 (f) “Participating Company” means each entity identified in the “General Information” section of this Plan, as may be
amended from time to time, which entity has, by action of its Board, elected to participate in the Plan. 
  
 (g) “Participant” means an Employee who has fulfilled the eligibility requirements of Article III. 
  
 (h) “Plan” means this ViroPharma Incorporated
Severance Pay Plan, as amended from time to time. 
  

 (i) “Plan Year” means the fiscal year of the Plan and is the 12-month period
ending each December 31. 
  
 (j) “Years of
Service” means the quotient obtained by dividing (i) total number of full calendar months that an Employee has performed services as an employee of his/her Participating Company by (ii) twelve (12). 
  
 III. PARTICIPATION 
  
 3.1. Eligibility for Benefits. An Employee shall be eligible for
severance benefits hereunder if his or her employment is terminated involuntarily by a Participating Company and the Administrator has determined that he or she is eligible for benefits, subject to Section 3.2 of this Plan as well as the following:

  
 (a) An Employee shall not be eligible for
benefits if (i) he or she is terminated by a Participating Company for misconduct or unsatisfactory performance or for any of the reasons identified in Section 5.7(a) of the ViroPharma Incorporated 2001 Equity Incentive Plan or (ii) he or she
voluntarily terminates his or her employment with a Participating Company for any reason. The Administrator shall have the sole discretion to determine an Employee’s eligibility hereunder, based on information provided to it by the Company,
subject to claims review pursuant to Section 5.5. 
  
 (b) An otherwise-eligible Employee who is absent on a leave under the Family and Medical Leave Act shall be eligible for benefits hereunder if the Employee is prepared to return to work at the end of such leave, if no position is offered to
such Employee by any Participating Company or by any purchaser of the Participating Company’s assets. Except as otherwise provided above, an Employee who is not actively at work at the time of his termination of employment will not be eligible
for benefits hereunder. 
  
 3.2. Loss of Eligibility. An
otherwise-eligible Employee will cease to be eligible for benefits under this Plan if: 
  
 (a) he or she fails to continue as a satisfactory Employee until the date that his or her employment is terminated by the Participating
Company in accordance with its business needs; 
  
 (b) either before or after a termination of his or her employment, he or she is offered a position with any Participating Company or an affiliate of any Participating Company (which may involve relocation of up to 50 miles) at a comparable
salary, for which the Participant is reasonably suited by reason of education, training or experience; 
  
 (c) either before or after a termination of his or her employment, he or she accepts a position with an affiliate of any Participating
Company, either in the United States or elsewhere; or 
  
 (d) the Participating Company has sold assets or otherwise transferred some portion or all of its business operations to another employer, and that employer has offered the Employee a position that provides a rate of compensation
substantially similar to that received by 

  

 -2- 

 
the Employee from the Participating Company immediately prior to his or her last day of employment with the Participating Company. 
  
 IV. SEPARATION BENEFITS 
  
 4.1. Basic Severance Benefits. A Participant may receive cash payments
and/or other benefits specified by the Administrator in a determination letter or memorandum sent to the Participant equal to one or more whole or fractional Months of Salary less any amount paid by the Participating Company or any affiliate
to the Participant in connection with his or her termination of employment in connection with the Company’s compliance with any federal or state law, including, without limitation any payment by the Participating Company or any affiliate
pursuant to the Worker Adjustment and Retraining Notification Act, as amended. The Administrator will condition the receipt of any payments and any other severance benefits (including subsidized group health benefits described in Section 4.2, below)
on the Participant’s execution of a release and return of Participating Company Property in accordance with Section 4.5. 
  
 4.2. Subsidized COBRA Coverage. If the Administrator so determines, a Participant may also be eligible to receive subsidized medical coverage under
the Consolidated Omnibus Budget Reconciliation Act (“COBRA”); provided, however, that such participation is conditioned on the following: 
  
 (a) The Participant is eligible for and elects to receive medical coverage under COBRA; 
  
 (b) The Administrator will specify the duration of the
subsidized medical coverage and the extent of the cost subsidy; 
  
 (c) The Participant will be required to pay any portion of the cost resulting from the continuation of medical coverage beyond the period of any subsidized medical coverage, if any, in such manner and at such times as
specified by the Administrator; and 
  
 (d) Such
subsidized coverage shall cease as of the date that the Participant and his spouse become eligible for group medical coverage from another employer (whether or not such coverage is actually elected) or as of such other date that continuation of
coverage under COBRA would have ceased for any reason. 
  
 4.3.
Payment of Benefits. All severance payments will be paid in the form of salary continuation; provided, however, that the Company may, in its sole discretion, pay the severance payments in a lump sum instead of salary continuation payments.
All severance payments hereunder will be subject to tax and other required withholding in accordance with the Company’s standard payroll practices. No severance payments will commence until eight days after receipt of a valid release signed by
the Participant, if such release is required. 
  
 4.4.
Documentation and Claim for Benefits. Normally, the Company will inform a Participant of his eligibility for benefits hereunder and benefits will be paid automatically. Any other Participant who believes he or she is eligible for benefits may
apply for benefits by submitting to the Administrator a written claim for benefits in accordance with Section 5.5. 
  

 -3- 

 4.5. Execution of Release and Return of Company Property Required. All benefits payable under the
Plan are conditioned on both the execution of a release (as outlined in this Section 4.5) and the return of all property owned by any Participating Company to the Administrator. No Participant will receive benefits in accordance with Section 4.2
unless the Participant otherwise satisfies the requirements for payment of benefits hereunder, signs a settlement agreement and release substantially in the form attached hereto as Exhibit A, and returns it to the Plan Administrator on or
within the period required by the Plan Administrator. No cash payments hereunder shall be made before the eighth day after the receipt of the release by the Administrator. To the extent permitted by law, all future benefits due under the Plan may be
suspended if the Participant revokes the release or otherwise repudiates it or breaches its terms. 
  
 4.6. Maximum Benefits. Notwithstanding any other provision of this Plan, the total severance payments paid hereunder to any Participant will not
exceed twice that Participant’s annual compensation in the year preceding his or her termination and will not be paid over a period extending more than 24 months beyond the date of that Participant’s termination. 
  
 V. ADMINISTRATION 
  
 5.1. Plan Administrator. The Administrator shall act as the
Plan’s administrator, as defined in Section 3(16)(A) of ERISA. The Administrator shall be charged with the interpretation, administration and operation of the Plan. 
  
 5.2. Delegation of Duties. The Administrator may delegate to any person or persons, severally or jointly, the
responsibility for the preparation and filing of all disclosure material and reports which the Administrator is required to file by law, and the responsibility for the day to day operation of the Plan. 
  
 5.3. Rules and Regulations. The Administrator, subject to the
provisions of the Plan, may adopt such rules and regulations as it deems necessary to carry out the provisions of the Plan. 
  
 5.4. Discretionary Actions. The Administrator shall have the power of full and final determination as to all issues concerning eligibility for
benefits under the Plan and interpretation of the Plan, and such determinations with respect to an Employee’s rights or benefits shall be entitled to the maximum deference permitted by law. 
  
 5.5. Benefit Claims Procedure. In accordance with Section 503 of ERISA
and the regulations of the Secretary of Labor prescribed thereunder: 
  
 (a) All claims for benefits under the Plan should be directed to the Administrator. Claims must be made in writing, should be executed and should include enough information to determine their validity. 
  
 (b) A decision will be issued no later than 90 days after
receiving enough information to process the claim, unless special circumstances require an additional 90 days for processing. If a claim is entirely or partly denied, the Participant will receive a written notice that will include the reason for the
denial, the portion of the Plan on which the denial is based, 

  

 -4- 

 
and an explanation of the claim review procedure. If the Participant’s claim was incomplete, the notice will say what additional information is needed.
If the Participant does not receive a response within 180 days after the Plan Administrator receives his or her claim, the claim is deemed denied. 
  
 (c) A Participant (or his or her beneficiary) is entitled to appeal a claim that is entirely or partly denied for a full and fair review.
The Participant’s appeal for a review must be made in writing and should be sent within 60 days after the Participant receives a notice of the denial of his or her claim, or within 60 days after the claim is deemed denied. The Participant will
receive a written notice of the decision on his or her appeal within 60 days after the request for review is received, unless special circumstances apply. 
  
 VI. MISCELLANEOUS 
  
 6.1. Right to Amend or Terminate. The Company reserves the right to amend the Plan, in whole or in part, or discontinue or terminate the Plan at
any time; provided, however, that any such amendment, discontinuance or termination shall not affect any right of any Participant to claim benefits under the provisions of Article IV for events occurring prior to the date of such amendment,
discontinuance or termination. 
  
 6.2. Benefits Payable from
General Assets. Benefits payable hereunder shall be paid exclusively from the general assets of the Company, and no person entitled to payment hereunder shall have any claim, right, security interest, or other interest in any fund, trust
account, insurance contracts or other asset of the Company. 
  
 6.3. No Contract for Continued Services. The Plan shall not be construed as creating any contract for continued services between the Company and the Participant, and nothing herein contained shall give the Participant the right to be
retained as an Employee of the Company. 
  
 6.4. Governing
Law. The Plan shall be construed as administered and enforced in accordance with ERISA and, where appropriate, the laws of the State of Delaware. 
  
 6.5. Definition of Words. Feminine or neuter pronouns shall be substituted for those of the masculine form, the plural shall be substituted for the
singular, and vice-versa, in any place or places herein where the context may require such substitution or substitutions. 
  
 6.6. Non-Alienation. No amount payable hereunder will be subject in any manner to alienation by anticipation, sale, transfer, assignment,
bankruptcy, pledge, attachment, charge or encumbrance of any kind, nor in any manner be subject to the debts or liabilities of any person. Any attempt by a Participant to alienate his or her benefits hereunder, whether presently or thereafter
payable, will be void. 
  

 -5- 

 ADDENDUM TO THE VIROPHARMA INCORPORATED 
 SEVERANCE PAY PLAN 
  
 This addendum is provided to enable this document to serve as, and to satisfy the requirements applicable to, a summary plan description. This addendum sets forth a Participant’s rights under ERISA and provides
general information regarding the Plan. 
  
 A Participant’s
Rights under ERISA 
 (Employee Retirement Income Security Act of 1974, as amended) 
  
 ERISA gives a Participant in the Plan certain rights and protections. A
Participant is entitled to: 
  

	 	•	 	Review, without charge, at the Plan administrator’s office and at other specified locations such as work sites, all Plan documents, and copies of all papers filed by the Plan
with the U.S. Department of Labor and available at the Public Disclosure Room of the Pension and Welfare Benefit Administration, including the Plan’s latest annual report (Form 5500 Series). 

  

	 	•	 	Receive copies of all documents governing the operation of the plan and copies of the latest annual report (Form 5500 Series) and an updated summary plan description. The
Administrator may make a reasonable charge for the copies. 

  

	 	•	 	Receive a summary of the Plan’s annual financial report. ERISA requires the Administrator to give each participant a copy of this summary annual report.

  
 Prudent Actions by Plan
Fiduciaries 
  
 In addition to creating rights for Plan
participants, ERISA imposes duties upon the people who are responsible for the operation of the Plan. The people who operate the Plan are called “fiduciaries.” They have a duty to act prudently and in the interest of each Participant in
the Plan and their beneficiaries. No one, including the Participant’s employer, union, or any other person, may fire the Participant or otherwise discriminate against the Participant in any way to prevent him or her from obtaining a welfare
benefit or exercising his or her rights under ERISA. 
  
 Enforcing Participants’ Rights 
  
 If a
Participant’s claim for a welfare benefit is denied or ignored, in whole or in part, that Participant has a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all
within certain time schedules. Under ERISA, there are steps a Participant can take to enforce his or her rights. For instance, if the Participant requests a copy of Plan documents or the latest annual report from the Administrator and does not
receive them within 30 days, the Participant may file suit in a federal court. In that case, the court may require the Administrator to provide the materials and pay the Participant up to $110 a day until he or she receives them, unless the
materials were not sent because of reasons beyond the Administrator’s control. If a Participant has a claim for benefits which is denied or ignored, in whole or in part, the Participant may file suit in a state or federal court. Of course, the
Company would suggest that the Participant follow the claims procedure provided in the Plan before suing. 
  
 If it should happen that Plan fiduciaries misuse the Plan’s money, or if a Participant is discriminated against for asserting his or her rights, the
Participant may ask for help from the U.S. Department of Labor or may sue in a federal court. The court will decide who has to pay court costs 

  

 
and legal fees. If the Participant wins, the court may order the person the Participant sued to pay these costs and fees. If the Participant loses, the court
may order the Participant to pay these costs and fees (for example, if it finds the Participant’s claim is frivolous). 
  
 Assistance with Questions 
  
 If any Participant has any questions about the Plan, that Participant should contact the Personnel Department. If a Participant has any questions about
this statement or about his or her rights under ERISA, or if he or she needs assistance in obtaining documents from the Administrator, the Participant should contact the nearest office of the Pension and Welfare Benefits Administration, U.S.
Department of Labor, listed in the telephone directory or the Division of Technical Assistance and Inquiries, Pension and Welfare Benefits Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210. The
Participant may also obtain certain publications about his or her rights and responsibilities under ERISA by calling the publications hotline of the Pension and Welfare Benefits Administration. 
  
 GENERAL INFORMATION 
  

			
	 Plan Name:
	  	ViroPharma Incorporated Severance Pay Plan.
		
	 Plan Type:
	  	The Plan is an employee welfare benefit plan, providing for the payment of severance benefits. All benefits under the Plan are paid from the general assets of the Company.
		
	 Plan Number:
	  	502.
		
	 Plan Effective Date:
	  	The Plan is effective as of July 15, 2002.
		
	 Plan Year:
	  	January 1 to December 31.
		
	 Plan Sponsor:
	  	 ViroPharma Incorporated
 405 Eagleview
Boulevard
 Exton, Pa 19341
 610-458-7300

		
	 Employer Identification Number:
	  	23-2789550
		
	 Participating Companies:
	  	ViroPharma Incorporated.
		
	 Plan Administrator:
	  	 ViroPharma Incorporated
 c/o Thomas Doyle

405 Eagleview Boulevard
 Exton, Pa 19341
 610-458-7300

		
	 Agent for Service of Legal Process:
	  	Same as Plan Administrator.

  

 EXHIBIT A 
  

SEPARATION AGREEMENT AND RELEASE 
  
 THIS SEPARATION AGREEMENT AND RELEASE (this “Agreement”) is made by and between
                     (“[NAME]”), and ViroPharma Incorporated, a Delaware corporation (the “Company”), which maintains its
principal place of business in Exton, Pennsylvania. [NAME] and the Company, each intending to be legally held bound, agree as follows: 
  
 6.6.1. Consideration. In consideration for a release of claims and other promises and covenants set forth herein, and after this
Agreement becomes effective as set forth in paragraph 8, the Company shall: pay [NAME] a total of $1,587.66, in 4 equal installments of $396.92 pursuant to the Company’s payroll practices in effect from time to time and subject to required tax
withholdings; if [NAME] elects COBRA coverage, fund such COBRA payments for 2 months; and provide career transition services through Drake Beam Morin. Payment shall be made following the expiration of the revocation period set forth in paragraph 8.

  
 6.6.2. Employee’s Release. [NAME]
generally releases and discharges the Company and its predecessors, successors (by merger or otherwise), parents, subsidiaries, affiliates and assigns, together with each and every of their present, past and future officers, directors, shareholders,
general partners, limited partners, employees and agents and the heirs and executors of same (herein collectively referred to as the “Company Group”) from any and all suits, causes of action, complaints, obligations, demands, common law or
statutory claims of any kind, whether in law or in equity, direct or indirect, known or unknown (hereinafter “claims”), which [NAME] ever had or now has against the Company, the Company Group, or any one of them arising out of or relating
to any matter, thing or event occurring up to and including the date of the this Agreement. This release specifically includes, but is not limited to: 
  
 (a) except in respect of the consideration provided by the Company in Section 1 above, any and all claims for wages and benefits
including, without limitation, salary, stock options, stock, royalties, license fees, health and welfare benefits, settlement pay, vacation pay, and bonuses; 
  

(b) any and all claims for wrongful discharge, breach of contract, whether express or implied, and claims for breach of implied
covenants of good faith and fair dealing; 
  
 (c)
any and all claims for alleged employment discrimination on the basis of race, color, religion, sex, age, national origin, veteran status, disability and/or handicap, in violation of any federal, state or local statute, ordinance, judicial precedent
or executive order, including but not limited to claims for discrimination under the following statutes: Title VII of the Civil Rights Act of 1964, 42 U.S.C. §2000e et seq.; the Civil Rights Act of 1866, 42 U.S.C. §1981; the Civil
Rights Act of 1991; the Age Discrimination in Employment Act, as amended, 29 U.S.C. §621 et seq.; the Older Workers Benefit Protection Act 29 U.S.C. §§ 623, 626 and 630; the Rehabilitation Act of 1972, as amended, 29
U.S.C. §701 et seq.; the Americans with Disabilities Act, 42 U.S.C. §12101 et seq.; the Family and Medical Leave Act of 1993, 29 U.S.C. §2601, et seq.; the Fair Labor Standards Act, as amended, 29 U.S.C.
§201, et seq.; the Fair Credit Reporting Act, as amended, 15 U.S.C. §1681, et seq.; and the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. §1000, et seq. (“ERISA”); 
  
 (d) any and all claims under any federal or state statute
relating to employee benefits or pensions; 
  

 (e) any and all claims in tort, including but not limited to, any claims for assault,
battery, misrepresentation, defamation, interference with contract or prospective economic advantage, intentional or negligent infliction of emotional distress, duress, loss of consortium, invasion of privacy and negligence; and 
  
 (f) any and all claims for attorneys’ fees and costs.

  
 6.6.3. Acknowledgment. [NAME]
understands that this Release extends to all of the aforementioned claims and potential claims which arose on or before the date of this Agreement, whether now known or unknown, suspected or unsuspected, and that this constitutes an essential term
of this Agreement. 
  
 6.6.4.
Confidentiality. No party shall disclose or publicize the terms of this Agreement to any person or entity, except that [NAME] may disclose the terms, and/or fact of this Agreement to immediate family members, [NAME]’s accountants and
attorneys and to others as required or permitted by law. 
  
 No
Disparagement. The parties shall not make any disparaging comments about the other. 
  
 6.6.5. Entire Agreement. This Agreement contains the entire agreement of the parties with respect to the subject matter hereof, and
shall be binding upon their respective heirs, executors, administrators, successors and assigns. 
  
 6.6.6. Severability. If any term or provision of this Agreement shall be held to be invalid or unenforceable for any reason, then
such term or provision shall be ineffective to the extent of such invalidity or unenforceability without invalidating the remaining terms or provisions hereof, and such term or provision shall be deemed modified to the extent necessary to make it
enforceable. 
  
 6.6.7. Advice of Counsel;
Revocation Period. [NAME] is hereby advised to seek the advice of counsel. [NAME] hereby acknowledges that he/she is acting of his/her own free will, that he/she has been afforded a reasonable time to read and review the terms of this Agreement,
and that he/she is voluntarily entering into this Agreement with full knowledge of its provisions and effects. [NAME] further acknowledges that he/she has been given at least FORTY-FIVE (45) days (until
                    ) within which to consider this Agreement and that he/she has SEVEN (7) days following his/her execution of this Agreement
to revoke his/her acceptance, with this Agreement not becoming effective until the revocation period has expired. We have attached as Exhibit A lists of those people described by job title and age, who were selected for reduction in force and who
received a similar offer and those people who were not selected for reduction in force, also described by job title and age. To accept this Agreement, [NAME] must sign and date this Agreement below and send it to the Company postmarked no later than
                    . If [NAME] elects to revoke his/her acceptance of this Agreement, [NAME] must provide written notice of such revocation
by certified mail (postmarked no later than seven days after the date [NAME] accepted this Agreement) to                      ,
ViroPharma Incorporated, 405 Eagleview Boulevard, Exton, Pennsylvania 19341. 
  
 6.6.8. Amendments. Neither this Agreement nor any term hereof may be orally changed, waived, discharged, or terminated, except by a written agreement signed by the parties hereto. 
  
 6.6.9. Governing Law; Forum Selection. This Agreement
shall be governed by the laws of the Commonwealth of Pennsylvania, without regard to the conflict of law principles of any jurisdiction. The parties agree that any disputes relating in any way to this Agreement shall be submitted exclusively to the
Court of Common Pleas, Chester County, Pennsylvania. 
  

 6.6.10. Legally Binding. The terms of this Agreement contained herein are
contractual, and not a mere recital. 
  
 IN WITNESS WHEREOF,
Frances [NAME], acting of free will after having had the opportunity to seek the advice of counsel and a reasonable period of time to consider the terms of this Agreement, and the Company, have caused the execution of this Agreement as of this day
and year written below. 
  

									
	 	 	 	 	 Witness:
	 	 
	 Frances [NAME]
	 	 	 	 	 	 
					
	 Date:
	 	 	 	 	 	 	 	 
				
	 VIROPHARMA INCOPRORATED
	 	 	 	 	 	 
					
	 By:
	 	 	 	 	 	 	 	 
					
	 Title:
	 	 	 	 	 	 	 	 
					
	 Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}]]